The draft guidance for industry outlines the scientific and ethical issues to address when considering the inclusion of pregnant women in clinical trials of drugs and biological products.
Medscape Medical News
This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.
Leave a Reply